| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Dec 05, 2025 | Sale | $20.72 | 2,662 | 55,157 | 196,877 | Dec 05, 2025, 04:11 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Sep 05, 2025 | Sale | $13.41 | 2,640 | 35,402 | 199,539 | Sep 09, 2025, 04:31 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Jul 14, 2025 | Buy | $9.11 | 100,000 | 911,000 | 242,179 | Jul 15, 2025, 05:11 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Jul 15, 2025 | Gift | - | 40,000 | - | 232,179 | Jul 15, 2025, 05:11 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Jun 05, 2025 | Sale | $13.35 | 4,060 | 54,201 | 142,179 | Jun 06, 2025, 04:07 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Mar 05, 2025 | Sale | $11.83 | 4,061 | 48,042 | 146,239 | Mar 07, 2025, 04:07 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Sep 04, 2024 | Buy | $33.04 | 8,000 | 264,304 | 8,000 | Sep 04, 2024, 05:42 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Sep 04, 2024 | Buy | $33.04 | 8,000 | 264,304 | 8,000 | Sep 04, 2024, 05:42 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Sep 04, 2024 | Buy | $33.04 | 8,000 | 264,304 | 8,000 | Sep 04, 2024, 05:42 PM |
| DYN | | Dyne Therapeutics, Inc. | John Cox | CEO & President | Sep 04, 2024 | Buy | $33.04 | 8,000 | 264,304 | 8,000 | Sep 04, 2024, 05:42 PM |
| RGEN | | REPLIGEN CORP | John Cox | Director | Mar 24, 2020 | Sale | $96.72 | 1,858 | 179,706 | 923 | Mar 26, 2020, 07:31 PM |
| RGEN | | REPLIGEN CORP | John Cox | Director | Mar 18, 2020 | Option/RSU Exercise | $24.37 | 26,736 | 651,603 | 29,517 | Mar 20, 2020, 04:25 PM |
| RGEN | | REPLIGEN CORP | John Cox | Director | Mar 18, 2020 | Sale | $95.27 | 26,736 | 2,547,035 | 4,984 | Mar 20, 2020, 04:25 PM |
| RGEN | | REPLIGEN CORP | John Cox | Director | Mar 04, 2020 | Option/RSU Exercise | $12.91 | 10,000 | 129,100 | 12,781 | Mar 05, 2020, 05:52 PM |
| RGEN | | REPLIGEN CORP | John Cox | Director | Mar 04, 2020 | Sale | $93.39 | 10,000 | 933,900 | 2,781 | Mar 05, 2020, 05:52 PM |
| RGEN | | REPLIGEN CORP | John Cox | Director | Feb 24, 2020 | Sale | $92.81 | 4,455 | 413,455 | 7,136 | Feb 26, 2020, 04:27 PM |
| BIIB | | BIOGEN INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2016 | Option/RSU Exercise | - | 810 | - | 30,898 | Feb 25, 2016, 05:04 PM |
| BIIB | | BIOGEN INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2016 | Tax Payment (Shares) | $258.99 | 382 | 98,934 | 30,516 | Feb 25, 2016, 05:04 PM |
| BIIB | | BIOGEN INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 12, 2016 | Tax Payment (Shares) | $247.22 | 1,552 | 383,685 | 30,088 | Feb 17, 2016, 06:01 PM |
| BIIB | | BIOGEN INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 12, 2016 | Option/RSU Exercise | - | 3,298 | - | 31,145 | Feb 17, 2016, 06:01 PM |
| BIIB | | BIOGEN INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 08, 2016 | Tax Payment (Shares) | $250.77 | 1,324 | 332,019 | 28,342 | Feb 09, 2016, 04:51 PM |
| BIIB | | BIOGEN INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 08, 2016 | Option/RSU Exercise | - | 4,026 | - | 29,666 | Feb 09, 2016, 04:51 PM |
| BIIB | | BIOGEN INC. | John Cox | EVP Pharmaceutical Oper & Tech | Mar 25, 2015 | Option/RSU Exercise | $65.85 | 5,066 | 333,571 | 37,577 | Mar 26, 2015, 04:31 PM |
| BIIB | | BIOGEN INC. | John Cox | EVP Pharmaceutical Oper & Tech | Mar 25, 2015 | Sale | $449.06 | 12,010 | 5,393,211 | 25,567 | Mar 26, 2015, 04:31 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 12, 2015 | Tax Payment (Shares) | $392.11 | 1,761 | 690,506 | 32,511 | Feb 17, 2015, 08:40 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 12, 2015 | Option/RSU Exercise | - | 3,738 | - | 33,214 | Feb 17, 2015, 08:40 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 09, 2015 | Tax Payment (Shares) | $396.88 | 2,210 | 877,105 | 30,534 | Feb 10, 2015, 05:07 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 09, 2015 | Option/RSU Exercise | - | 4,691 | - | 32,744 | Feb 10, 2015, 05:07 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 08, 2015 | Tax Payment (Shares) | $402.00 | 1,537 | 617,874 | 28,053 | Feb 10, 2015, 05:07 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 08, 2015 | Option/RSU Exercise | - | 4,023 | - | 29,590 | Feb 10, 2015, 05:07 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2014 | Tax Payment (Shares) | $347.11 | 1,228 | 426,251 | 25,478 | Feb 25, 2014, 02:17 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2014 | Option/RSU Exercise | - | 2,598 | - | 26,706 | Feb 25, 2014, 02:17 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 12, 2014 | Option/RSU Exercise | - | 2,246 | - | 25,167 | Feb 14, 2014, 04:34 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 12, 2014 | Tax Payment (Shares) | $323.04 | 1,059 | 342,099 | 24,108 | Feb 14, 2014, 04:34 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 08, 2014 | Option/RSU Exercise | - | 4,023 | - | 21,883 | Feb 11, 2014, 06:07 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 09, 2014 | Tax Payment (Shares) | $315.54 | 2,212 | 697,974 | 22,921 | Feb 11, 2014, 06:07 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 09, 2014 | Option/RSU Exercise | - | 4,691 | - | 25,133 | Feb 11, 2014, 06:07 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 08, 2014 | Tax Payment (Shares) | $315.54 | 1,441 | 454,693 | 20,442 | Feb 11, 2014, 06:07 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 25, 2013 | Gift | - | 200 | - | 17,860 | Dec 04, 2013, 12:05 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | May 03, 2013 | Tax Payment (Shares) | $218.85 | 866 | 189,524 | 18,060 | May 07, 2013, 01:33 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2013 | Tax Payment (Shares) | $164.40 | 1,227 | 201,719 | 18,759 | Feb 26, 2013, 01:26 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2013 | Option/RSU Exercise | - | 2,598 | - | 19,986 | Feb 26, 2013, 01:26 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 09, 2013 | Option/RSU Exercise | - | 4,692 | - | 19,224 | Feb 12, 2013, 05:10 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 08, 2013 | Tax Payment (Shares) | $164.44 | 1,133 | 186,311 | 14,532 | Feb 12, 2013, 05:10 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 08, 2013 | Option/RSU Exercise | - | 3,487 | - | 15,665 | Feb 12, 2013, 05:10 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 09, 2013 | Tax Payment (Shares) | $164.44 | 1,836 | 301,912 | 17,388 | Feb 12, 2013, 05:10 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | May 03, 2012 | Tax Payment (Shares) | $134.26 | 765 | 102,709 | 12,178 | May 04, 2012, 02:03 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 24, 2012 | Tax Payment (Shares) | $116.39 | 1,578 | 183,663 | 13,506 | Feb 27, 2012, 04:19 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2012 | Tax Payment (Shares) | $116.70 | 1,085 | 126,619 | 14,291 | Feb 27, 2012, 04:19 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2012 | Option/RSU Exercise | - | 2,600 | - | 15,376 | Feb 27, 2012, 04:19 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 09, 2012 | Tax Payment (Shares) | $117.78 | 1,504 | 177,141 | 12,776 | Feb 13, 2012, 04:28 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 09, 2012 | Option/RSU Exercise | - | 4,692 | - | 14,280 | Feb 13, 2012, 04:28 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 01, 2011 | Sale | $114.37 | 2,175 | 248,755 | 9,588 | Nov 03, 2011, 10:52 AM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 01, 2011 | Option/RSU Exercise | $72.87 | 2,175 | 158,492 | 11,763 | Nov 03, 2011, 10:52 AM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | May 03, 2011 | Tax Payment (Shares) | $97.99 | 765 | 74,962 | 9,588 | May 04, 2011, 02:51 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Apr 21, 2011 | Option/RSU Exercise | $72.87 | 4,350 | 316,985 | 14,703 | Apr 25, 2011, 02:02 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Apr 21, 2011 | Sale | $100.00 | 4,350 | 435,000 | 10,353 | Apr 25, 2011, 02:02 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Apr 13, 2011 | Option/RSU Exercise | $56.73 | 36,234 | 2,055,646 | 46,587 | Apr 15, 2011, 11:50 AM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Apr 13, 2011 | Sale | $80.00 | 36,234 | 2,898,720 | 10,353 | Apr 15, 2011, 11:50 AM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Apr 11, 2011 | Option/RSU Exercise | $47.92 | 6,900 | 330,648 | 17,253 | Apr 13, 2011, 10:14 AM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Apr 11, 2011 | Sale | $78.00 | 6,900 | 538,200 | 10,353 | Apr 13, 2011, 10:14 AM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Mar 31, 2011 | Option/RSU Exercise | $43.50 | 2,840 | 123,540 | 12,658 | Apr 01, 2011, 03:20 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Mar 31, 2011 | Sale | $73.00 | 2,840 | 207,320 | 9,818 | Apr 01, 2011, 03:20 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Mar 02, 2011 | Sale | $70.10 | 4,041 | 283,259 | 12,401 | Mar 03, 2011, 03:10 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 24, 2011 | Tax Payment (Shares) | $67.26 | 1,202 | 80,847 | 14,463 | Feb 28, 2011, 03:32 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2011 | Tax Payment (Shares) | $66.76 | 680 | 45,397 | 15,190 | Feb 25, 2011, 03:56 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 23, 2011 | Option/RSU Exercise | - | 2,138 | - | 15,741 | Feb 25, 2011, 03:56 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 17, 2011 | Sale | $67.08 | 1,843 | 123,620 | 13,603 | Feb 18, 2011, 03:06 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Feb 12, 2011 | Tax Payment (Shares) | $65.83 | 910 | 59,905 | 15,446 | Feb 15, 2011, 02:27 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 09, 2010 | Sale | $62.87 | 773 | 48,597 | 16,356 | Nov 10, 2010, 02:21 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 09, 2010 | Sale | $62.87 | 773 | 48,597 | 16,356 | Nov 10, 2010, 02:21 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 01, 2010 | Tax Payment (Shares) | $62.55 | 360 | 22,518 | 17,894 | Nov 03, 2010, 01:50 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 01, 2010 | Tax Payment (Shares) | $62.55 | 360 | 22,518 | 17,894 | Nov 03, 2010, 01:50 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 02, 2010 | Sale | $63.04 | 765 | 48,228 | 17,129 | Nov 03, 2010, 01:50 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Nov 02, 2010 | Sale | $63.04 | 765 | 48,228 | 17,129 | Nov 03, 2010, 01:50 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Option/RSU Exercise | $33.97 | 6,900 | 234,393 | 25,154 | Oct 29, 2010, 02:25 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Sale | $63.00 | 6,900 | 434,700 | 18,254 | Oct 29, 2010, 02:25 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Option/RSU Exercise | $33.97 | 6,900 | 234,393 | 25,154 | Oct 29, 2010, 02:25 PM |
| BIIB | | BIOGEN IDEC INC. | John Cox | EVP Pharmaceutical Oper & Tech | Oct 28, 2010 | Sale | $63.00 | 6,900 | 434,700 | 18,254 | Oct 29, 2010, 02:25 PM |
